Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

It has been a banner year for biotech buyouts, and these are two of the prime targets.

Biotechnology is enjoying one of its strongest years in recent times, which is mostly fueled by a rebound in capital markets, ...

We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Jade Biosciences, Inc. (NASDAQ:JBIO) ...

Wolfspeed topped the list of the most heavily shorted U.S.-listed stocks with market capitalizations above $2B, with 53.77% ...

Three biotech stocks in the IBD 50 are setting up in bases while a fourth is pulling back from highs as the first-quarter earnings season gets into full swing. Travere TherapeuticsTVTX, part of IBD's ...

If you're looking to diversify outside of AI, especially as AI investors look to trim their winners to save up for that mega-cap AI IPO boom on the horizon, with SpaceX leading the way, the biotech ...

Patent cliffs are forcing Big Pharma to hunt for revenue-producing biotech assets, and three names keep surfacing in deal ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...

AbbVie (ABBV) shares climbed roughly 2% in premarket trading Thursday after the pharma giant raised its full-year earnings outlook on the back of a strong first-quarter revenue beat, and the results ...

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC's Halftime Report this week about large-cap biotech: "These are growth stocks where you don't have to worry about disruption ...